id	keyword
ijpds-3747	belimumab
ijpds-3747	hcq
ijpds-3747	disorders
ijpds-3747	risk
ijpds-3747	sle
ijpds-3747	trials
ijpds-3747	ratio
ijpds-3747	lupus
ijpds-3747	safety
ijpds-3747	effects
ijpds-3747	results